eGenesis Logo - Engineering Hope.png
eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer
April 19, 2022 08:30 ET | eGenesis
Dr. Curtis succeeds Paul Sekhri, who remains on Board of Directors Reflects company’s focus on advancement of portfolio toward clinical development CAMBRIDGE, Mass., April 19, 2022 (GLOBE...
eGenesis Logo - Engineering Hope.png
eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer
April 04, 2022 08:30 ET | eGenesis
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of Eliezer...
eGenesis Logo - Engineering Hope.png
eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model
March 09, 2022 08:30 ET | eGenesis
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing company developing human-compatible (HuCo™) organs and cells, today announced the initiation of a research collaboration...
eGenesis Logo - Engineering Hope.png
eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors
June 09, 2021 08:00 ET | eGenesis
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of...
eGenesis Logo - Engineering Hope.png
eGenesis Expands Research Collaboration with Leading Academic Medical Center
April 01, 2021 08:00 ET | eGenesis
Collaboration will now include in vivo testing of lead kidney xenotransplant program in addition to pancreatic islet xenotransplant program CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) --...
eGenesis Logo - Engineering Hope.png
eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer
March 04, 2021 08:00 ET | eGenesis
CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs, tissues, and cells, today announced the appointment...
eGenesis Logo - Engineering Hope.png
eGenesis Announces $125 Million Series C Financing
March 02, 2021 08:00 ET | eGenesis
CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs, tissues, and cells, today announced the successful...
eGenesis Logo - Engineering Hope.png
eGenesis Announces Research Collaboration with Leading Academic Medical Center
November 05, 2020 08:30 ET | eGenesis
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs,...
eGenesis Logo - Engineering Hope.png
eGenesis Appoints Veteran Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research & Development
September 01, 2020 08:00 ET | eGenesis
CAMBRIDGE, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs,...
eGenesis Logo - Engineering Hope.png
eGenesis Appoints Accomplished Biopharmaceutical Executive, Peter Hanson, DVM, Ph.D., as Chief Operating Officer
July 01, 2020 08:00 ET | eGenesis
CAMBRIDGE, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs,...